QLGN -
Qualigen Therapeutics, Inc. Common Stock
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 3.92 0.07 (1.79%) |
--- |
--- |
0.0 (0.0%) |
-0.07 (-1.79%) |
0.19 (5.0%) |
0.0 (0.0%) |
0.0 (0.0%) |
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
Earnings & Ratios
- Basic EPS:
- -1.0
- Diluted EPS:
- -1.0
- Basic P/E:
- -3.99
- Diluted P/E:
- -3.99
- RSI(14) 1m:
- 100.0
- VWAP:
- 3.99
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Oct 13, 2025 01:00
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Recent Developments Include FX Signing a Deposit Agreement for 1,000 FX Super One MPV’s with ZEVO, a Pioneer of Peer-to-Peer EV Sharing Platform in the U.S.
Oct 12, 2025 23:30
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Oct 06, 2025 23:00
Faraday Future Issues a Statement on a Recent Fire Incident at Its Satellite Office Building
Oct 01, 2025 00:48
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)
Sep 30, 2025 20:00
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume Market
Sep 29, 2025 01:32
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction
Sep 19, 2025 23:24
Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Nov 25, 2024 22:00
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering
Sep 05, 2024 13:00
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Jul 16, 2024 09:51